|Mr. Kent J. Thiry||Chairman & CEO||3.68M||N/A||61|
|Mr. James K. Hilger||Chief Accounting Officer||877.47k||264.36k||55|
|Ms. Kathleen Alyce Waters||Chief Legal Officer||1.07M||N/A||49|
|Mr. Javier J. Rodriguez||Chief Exec. Officer of Kidney Care||6.12M||8.8M||46|
|Ms. LeAnne M. Zumwalt||Group VP of Purchasing & Public Affairs||1.18M||946k||58|
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). It operates through two divisions, DaVita Kidney Care and DaVita Medical Group. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers, as well as patient and physician focused integrated health care delivery and management services. In addition, the company operates DaVita Rx, a pharmacy that provides oral medications to patients with ESRD; disease management services; vascular access services; clinical research programs; physician services; and direct primary care services. As of December 31, 2016, it provided dialysis and administrative services in the United States through a network of 2,350 outpatient dialysis centers serving approximately 187,700 patients; and operated 154 outpatient dialysis centers located in 11 countries outside of the United States. Further, the company provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was founded in 1994 and is headquartered in Denver, Colorado.
DaVita Inc.’s ISS Governance QualityScore as of August 1, 2017 is 1. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 2; Compensation: 2.